Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trialJean-Marc Classe, Olivier Gléhen, Gilles Houvenaeghel et al.|The Lancet Oncology|2024Cited by 70
Validation Of The Association Between Aletti Score And Occurrence Of Serious Postoperative Complications In A Multicenter Cohort Following Cytoreductive Surgery In Advanced Ovarian CancerDelphine Hudry, Fabrice Narducci, Elisa Scarpelli et al.|International Journal of Gynecological Cancer|2025Cited by 0
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer (CHIPOR): A Randomized, Open-Label, Phase 3 TrialJean-Marc Classe, Olivier Gléhen, Pierre Méeus et al.|Obstetrical & Gynecological Survey|2025Cited by 0